ARID1A Mutation in Metastatic Breast Cancer: A Potential Therapeutic Target
Distant metastasis is the principal cause of mortality for breast cancer patients. Targeting specific mutations that have been acquired during the evolution process of advanced breast cancer is a potential means of enhancing the clinical efficacy of treatment strategies. In metastatic breast cancer,...
Enregistré dans:
Auteurs principaux: | Xuan Cheng, Jian-Xiong Zhao, Feng Dong, Xu-Chen Cao |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cb7b9d2bd5ac409393c064b6b03f2372 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Single-PanIN-seq unveils that ARID1A deficiency promotes pancreatic tumorigenesis by attenuating KRAS-induced senescence
par: Shou Liu, et autres
Publié: (2021) -
Identification of de novo mutations for ARID1B haploinsufficiency associated with Coffin–Siris syndrome 1 in three Chinese families via array-CGH and whole exome sequencing
par: Guanting Lu, et autres
Publié: (2021) -
Acute depletion of the ARID1A subunit of SWI/SNF complexes reveals distinct pathways for activation and repression of transcription
par: Seraina Blümli, et autres
Publié: (2021) -
Metastatic breast cancer: Endocrine therapy landscape reshaped
par: Mohamad Adham Salkeni, et autres
Publié: (2017) -
The Genomic Landscape of the Fungus-Specific SWI/SNF Complex Subunit, Snf6, in <named-content content-type="genus-species">Candida albicans</named-content>
par: Faiza Tebbji, et autres
Publié: (2017)